Advertisement
Advertisement

ZYME

ZYME logo

Zymeworks Inc.

22.54
USD
Sponsored
+0.16
+0.71%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

22.54

0.00
0.00%

ZYME Earnings Reports

Positive Surprise Ratio

ZYME beat 23 of 34 last estimates.

68%

Next Report

Date of Next Report
Mar 03, 2026
Estimate for Q4 25 (Revenue/ EPS)
$13.85M
/
-$0.43
Implied change from Q3 25 (Revenue/ EPS)
-49.85%
/
+65.38%
Implied change from Q4 24 (Revenue/ EPS)
-55.37%
/
+38.71%

Zymeworks Inc. earnings per share and revenue

On Nov 06, 2025, ZYME reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 20.63% surprise. Revenue reached 27.61 million, compared to an expected 30.05 million, with a -8.10% difference. The market reacted with a -8.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.43 USD, with revenue projected to reach 13.85 million USD, implying an increase of 65.38% EPS, and decrease of -49.85% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Zymeworks Inc. reported EPS of -$0.26, beating estimates by 20.63%, and revenue of $27.61M, -8.1% below expectations.
The stock price moved down -8.04%, changed from $17.90 before the earnings release to $16.46 the day after.
The next earning report is scheduled for Mar 03, 2026.
Based on 14 analysts, Zymeworks Inc. is expected to report EPS of -$0.43 and revenue of $13.85M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement